Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Consensus
Buy3.67 / 5
3 ratings · Buy 2 · Hold 1
4 ratings older than 2 years not counted
Price vs analyst targets
Revenue and EPS estimates
Reported
Consensus estimates
Fiscal period
FY2023Dec '23
FY2024Dec '24
FY2025Dec '25
FY2026Dec '26
FY2027Dec '27
FY2028Dec '28
FY2029Dec '29
Revenue (B)
14.52
14.62
15.77
121.06
130.24
139.06
151.11
Growth YoY
+1.7%
+0.7%
+7.9%
+667.7%
+7.6%
+6.8%
+8.7%
High estimate
–
–
–
122.34
131.32
150.29
160.34
Low estimate
–
–
–
120.26
127.68
122.49
138.51
Analysts
–
–
–
24
24
28
22
EPS, adjusted
7.02
6.98
8.12
61.56
71.46
77.50
87.02
Growth YoY
+37.6%
−0.6%
+16.3%
+658.1%
+16.1%
+8.5%
+12.3%
High estimate
–
–
–
62.68
72.85
89.16
93.93
Low estimate
–
–
–
60.50
70.06
71.84
77.59
Analysts
–
–
–
13
13
11
4
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
Brokers
7 firms active in the last 12 months
Firm
Analyst
Rating
Prev rating
Target
Prev target
Chg
Upside
Date
Morgan Stanley
Yang Liu
Overweight
Overweight
$163.00
$158.00
+3%
+33%
Sep 28
BNP Paribas
–
Buy · Sep 2013 · not counted
Buy
$180.00
–
–
+47%
Sep 22
Bernstein
Robin Zhu
Outperform · Jun 2023 · not counted
Outperform
$160.00
$155.00
+3%
+30%
Aug 21
Goldman Sachs
–
Buy · Dec 2019 · not counted
Neutral
$169.00
$161.00
+5%
+38%
Jul 1
Barclays
–
Equal Weight
Equal Weight
$132.00
$135.00
−2%
+8%
Feb 12
Macquarie
–
Neutral · May 2021 · not counted
Neutral
$158.00
$129.00
+22%
+29%
Feb 12
Benchmark
–
Buy
Buy
–
–
–
–
Nov 21, 2025
Latest analyst action · Page refreshed hourly; analyst feeds refreshed daily · About this data